Page last updated: 2024-10-26

dipyridamole and Vocal Cord Paralysis

dipyridamole has been researched along with Vocal Cord Paralysis in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Vocal Cord Paralysis: Congenital or acquired paralysis of one or both VOCAL CORDS. This condition is caused by defects in the CENTRAL NERVOUS SYSTEM, the VAGUS NERVE and branches of LARYNGEAL NERVES. Common symptoms are VOICE DISORDERS including HOARSENESS or APHONIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaushal, R1
Dash, SC1
Kapur, S1
Bhuyan, UN1

Other Studies

1 other study available for dipyridamole and Vocal Cord Paralysis

ArticleYear
Wegener's granulomatosis with rapidly progressive glomerulonephritis.
    The Journal of the Association of Physicians of India, 1987, Volume: 35, Issue:5

    Topics: Adult; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis; Granulomatosis

1987